8-18064458-T-G

Variant summary

Our verdict is Pathogenic. The variant received 13 ACMG points: 14P and 1B. PS3PM2PP5_Very_StrongBP4

The NM_177924.5(ASAH1):​c.456A>C​(p.Lys152Asn) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000092 in 1,553,542 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/26 in silico tools predict a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV001161424: Acid ceramidase enzyme activity was measured in this patient's and mother's fibroblasts. The patient has approximately 15% enzyme activity of controls and the mother has acid ceramidase activity of approximately 50% normal. DOI: 10.1016/j.nmd.2015.09.007" and additional evidence is available in ClinVar. Synonymous variant affecting the same amino acid position (i.e. K152K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000039 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000098 ( 0 hom. )

Consequence

ASAH1
NM_177924.5 missense, splice_region

Scores

4
14
Splicing: ADA: 0.1912
2

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:5U:1

Conservation

PhyloP100: 1.30

Publications

12 publications found
Variant links:
Genes affected
ASAH1 (HGNC:735): (N-acylsphingosine amidohydrolase 1) This gene encodes a member of the acid ceramidase family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. Processing of this preproprotein generates alpha and beta subunits that heterodimerize to form the mature lysosomal enzyme, which catalyzes the degradation of ceramide into sphingosine and free fatty acid. This enzyme is overexpressed in multiple human cancers and may play a role in cancer progression. Mutations in this gene are associated with the lysosomal storage disorder, Farber lipogranulomatosis, and a neuromuscular disorder, spinal muscular atrophy with progressive myoclonic epilepsy. [provided by RefSeq, Oct 2015]
ASAH1 Gene-Disease associations (from GenCC):
  • ASAH1-related sphingolipidosis
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Farber lipogranulomatosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Orphanet
  • spinal muscular atrophy-progressive myoclonic epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 13 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV001161424: Acid ceramidase enzyme activity was measured in this patient's and mother's fibroblasts. The patient has approximately 15% enzyme activity of controls and the mother has acid ceramidase activity of approximately 50% normal. DOI: 10.1016/j.nmd.2015.09.007; SCV000994982: RNA studies demonstrate in-frame skipping of exon 6 (PMID: 24164096); SCV004720033: Functional studies in cultured fibroblasts showed significantly reduced acid ceramidase enzymatic activity (Dyment et al. 2014. Pubmed ID: 24164096).
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 8-18064458-T-G is Pathogenic according to our data. Variant chr8-18064458-T-G is described in ClinVar as Pathogenic. ClinVar VariationId is 180643.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.18940812). . Strength limited to SUPPORTING due to the PP5.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_177924.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ASAH1
NM_177924.5
MANE Select
c.456A>Cp.Lys152Asn
missense splice_region
Exon 6 of 14NP_808592.2Q13510-1
ASAH1
NM_004315.6
c.504A>Cp.Lys168Asn
missense splice_region
Exon 6 of 14NP_004306.3
ASAH1
NM_001127505.3
c.438A>Cp.Lys146Asn
missense splice_region
Exon 6 of 14NP_001120977.1Q13510-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ASAH1
ENST00000637790.2
TSL:1 MANE Select
c.456A>Cp.Lys152Asn
missense splice_region
Exon 6 of 14ENSP00000490272.1Q13510-1
ASAH1
ENST00000381733.9
TSL:1
c.504A>Cp.Lys168Asn
missense splice_region
Exon 6 of 14ENSP00000371152.4Q13510-2
ASAH1
ENST00000314146.10
TSL:1
c.438A>Cp.Lys146Asn
missense splice_region
Exon 6 of 14ENSP00000326970.10Q13510-3

Frequencies

GnomAD3 genomes
AF:
0.0000394
AC:
6
AN:
152218
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000576
AC:
14
AN:
243106
AF XY:
0.0000304
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000146
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000470
Gnomad NFE exome
AF:
0.0000734
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000978
AC:
137
AN:
1401324
Hom.:
0
Cov.:
28
AF XY:
0.0000900
AC XY:
63
AN XY:
699890
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31866
American (AMR)
AF:
0.000180
AC:
8
AN:
44350
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25592
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
84456
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52878
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5634
European-Non Finnish (NFE)
AF:
0.000114
AC:
121
AN:
1058978
Other (OTH)
AF:
0.000137
AC:
8
AN:
58384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.432
Heterozygous variant carriers
0
6
12
19
25
31
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000394
AC:
6
AN:
152218
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41456
American (AMR)
AF:
0.000131
AC:
2
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5200
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68042
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000774
Hom.:
0
Bravo
AF:
0.0000453
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.0000741
AC:
9

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
2
1
-
Spinal muscular atrophy-progressive myoclonic epilepsy syndrome (3)
2
-
-
not provided (2)
1
-
-
ASAH1-related disorders (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.089
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.39
CADD
Benign
16
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.42
T
Eigen
Benign
-0.43
Eigen_PC
Benign
-0.22
FATHMM_MKL
Uncertain
0.85
D
LIST_S2
Benign
0.74
T
M_CAP
Uncertain
0.27
D
MetaRNN
Benign
0.19
T
MetaSVM
Benign
-0.88
T
MutationAssessor
Benign
0.81
L
PhyloP100
1.3
PrimateAI
Benign
0.25
T
PROVEAN
Benign
-0.21
N
REVEL
Benign
0.24
Sift
Benign
0.42
T
Sift4G
Benign
0.68
T
Polyphen
0.0010
B
Vest4
0.21
MVP
0.82
MPC
0.0029
ClinPred
0.052
T
GERP RS
5.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.27
gMVP
0.79
Mutation Taster
=7/93
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.19
dbscSNV1_RF
Benign
0.41
SpliceAI score (max)
0.41
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.41
Position offset: -1

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200455852; hg19: chr8-17921967; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.